Beacon Biosignals is a neurotechnology company that develops an AI-powered platform for interpreting brain data to advance treatments for neurological and psychiatric diseases. Beacon Biosignals leverages FDA-cleared EEG wearables, proprietary machine learning algorithms, and large-scale datasets to help accelerate the development and delivery of new therapies for disorders of the brain.
The company’s platform collects and analyzes brain signals using advanced software engineering and artificial intelligence. By providing actionable insights from EEG (electroencephalogram) data, Beacon Biosignals aims to transform how patients with conditions such as epilepsy, sleep disorders, and other neurological or psychiatric diseases are diagnosed, monitored, and treated. Their technology is designed to support pharmaceutical companies and clinical researchers in evaluating treatment efficacy and understanding brain activity at scale.
Who Uses Beacon Biosignals?
Beacon Biosignals primarily serves biopharmaceutical companies and research organizations that are developing new therapies for brain-related disorders. Notable customers include Bristol-Myers Squibb (BMS), UCB, Takeda, and Novartis, reflecting Beacon’s focus on supporting leading industry players in clinical development and research.
How Was Beacon Biosignals Started?
Beacon Biosignals was founded by a multidisciplinary team with strong expertise in neuroscience, medicine, and software engineering. The founding team includes:
- Jacob Donoghue, MD PhD (CEO & Co-Founder): Trained as a neuroscientist and physician, Jacob’s research at Harvard and MIT focused on neuroactive compounds and machine learning for neural data.
- Jarrett Revels (CTO & Co-Founder): An MIT-trained engineer known for his work on machine learning frameworks and scientific computing tools.
- Brandon Westover, MD PhD (Co-Founder): A professor of neurology at Harvard Medical School, leading AI-driven clinical data initiatives.
- Sydney Cash, MD PhD (Co-Founder): Associate Professor at Harvard Medical School and a pioneer in neurotechnology and epilepsy research.
Their combined backgrounds in research, clinical care, and technical innovation underpin Beacon Biosignals’ mission to bridge the gap between cutting-edge science and practical healthcare solutions. Find more about their team on their About page.
What Makes Beacon Biosignals Distinctive?
Beacon Biosignals differentiates itself by integrating FDA-cleared EEG hardware with scalable AI analytics tailored for brain data. This end-to-end approach enables more precise measurement of neurological function and drug effects, supporting a data-driven path to new treatments in a field traditionally reliant on subjective assessment.
Use PromptLoop to Uncover Company Data
Looking for more company insights like this? PromptLoop helps you go deeper, providing unique data points and analysis on companies like Beacon Biosignals and many others. Automate your research and find the information that matters most. Discover how PromptLoop can accelerate your market intelligence. Get A Free Demo to learn more.